Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-Label Progesterone Use For Preventing Preterm Birth Debated At FDA Panel

Executive Summary

Some members of FDA’s Reproductive Health Drugs Advisory Committee were not impressed that progesterone is already being used off-label to prevent preterm birth in women with a short cervix.

You may also be interested in...



Watson May Bypass Progesterone Gel 8% For Second-Generation Product

The extent of additional clinical work required pursuant to an FDA “complete response” letter will have to be balanced against the remaining patent life on the product, for which Watson was seeking an indication to prevent preterm birth in women with a short cervix.

Can Watson Give Birth To A Pregnancy Franchise As It Helps Lay Lipitor To Rest?

Watson is progressing on a multi-year effort to diversify beyond its core U.S. generics business into branded drugs and international markets.

Janssen’s Sirturo Needs Minor Tweaks To Confirmatory Trial, FDA Panel Says

Gathering more data to assuage concerns about possibly lower efficacy in black patients will be key to converting the accelerated approval to full approval for the tuberculosis drug, FDA’s Anti-Infective Drugs Advisory Committee concludes.

Topics

Related Companies

UsernamePublicRestriction

Register

PS054261

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel